Moolec Science (MLEC) Cash & Current Investments (2022 - 2026)
Moolec Science (MLEC) reported Cash & Current Investments of $1.2 million for Q1 2026, up 20.0% sequentially from $1.0 million in Q4 2025.
Moolec Science (MLEC) Cash & Current Investments (2022 - 2026) Analysis & Trends
Moolec Science (MLEC) has 5 years of Cash & Current Investments data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $9.0 million, down 86.67% from the prior year.
- Cash & Current Investments grew to $1.2 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $228.0 million in Q1 2023 to a low of $853857.0 in Q3 2023.
- A 5-year average of $39.5 million and a median of $10.4 million in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments jumped 373.64% in 2023 and sank 98.14% in 2024, its largest moves.
- Tracing MLEC's Cash & Current Investments over 5 years: stood at $10.4 million in 2022, then jumped by 373.64% to $49.4 million in 2023, then advanced by 7.28% to $53.0 million in 2024, then plunged by 98.11% to $1.0 million in 2025, then climbed by 20.0% to $1.2 million in 2026.
- Business Quant data shows MLEC's Cash & Current Investments at $1.2 million in Q1 2026, $1.0 million in Q4 2025, and $9.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Jun 30, 2025 | 9.02 Mn |
| Dec 31, 2024 | 52.99 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 67.66 Mn |
| Mar 31, 2024 | 4.25 Mn |
| Dec 31, 2023 | 49.40 Mn |
| Sep 30, 2023 | 853,857.00 |
| Jun 30, 2023 | 49.57 Mn |
| Mar 31, 2023 | 228.00 Mn |
| Dec 31, 2022 | 10.43 Mn |
| Jun 30, 2022 | 35.93 Mn |